Increased Statin Prescribing Does Not Lower Pneumonia Risk
Author(s) -
Linnea A. Polgreen,
Elizabeth Cook,
John M. Brooks,
Yuexin Tang,
Philip M. Polgreen
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ190
Subject(s) - medicine , pneumonia , hydroxymethylglutaryl coa reductase inhibitors , statin , intensive care medicine
Investigators have attributed protective effects of statins against pneumonia and other infections. However, these reports are based on observational data where treatments are not assigned randomly. We aimed to determine if the protective effects of statins against pneumonia are due to nonrandom treatment assignment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom